The role of environmental factors and molecular genetics diagnosis in treatment of breast cancer in Iran, Qom (2019-2020)

被引:0
|
作者
Miryousefiata, Faegheh [1 ]
Sangy, Sareh [2 ]
机构
[1] Gunesli Erdem Hosp, Emergency Dept, Istanbul, Turkey
[2] Iran Univ Med Cciences, Dept Tradit Med Clin, Ponak Salamatkadeh, Tehran, Iran
来源
MEDICINA BALEAR | 2022年 / 37卷 / 02期
关键词
Cancer; breast; molecular genetics; diagnosis; treatment; BRCA1; SUSCEPTIBILITY; FAMILIES;
D O I
10.3306/AJHS.2022.37.02.122
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cancer is one of the leading causes of death and disability worldwide, especially in developing countries. Development is considered. In most cases, cancer is not because of the person's innate biology, but because of the environment in which the person lives are created. In this study, the available evidence on the role of environmental factors and how they affect the incidence of cancer Has been reviewed. BRCA1 and BRCA2 are the two most important high-risk genes for hereditary breast cancer. A significant proportion of familial breast cancer is caused by mutations in the CHEK2 gene. Other gene susceptibility alleles are also uncommon causes of breast cancer. More than 1000 mutations in BRCA1 and BRCA2 have been found, and molecular techniques for detecting mutations in these genes are now well established. Mutations in BRCA1 and BRCA2 generate genomic instability, which leads to changes in other important genes, such as tumor suppressor genes and/or oncogenes. In the near future, there is the possibility of personalizing treatment plans for individual women. The discovery of miRNAs as gene expression regulators establishes them as a novel candidate for diagnostic and prognostic markers, as well as therapeutic targets. Information related to crime victims Cancer patients during the years 2019 to 2020 in Iran in Qom city. It was recorded that it has been collected and has been analyzed and analyzed. In this review the PARS codes. They are used as diagnostic codes for breast cancer are ICD of 10 C50. The number of registered breast cancers during these three years was 399. The number of registered breast cancers during these three years has been 399.
引用
收藏
页码:122 / 126
页数:5
相关论文
共 17 条
  • [1] Laboratory diagnosis of measles infection using molecular and serology during 2019-2020 outbreak in Brazil
    Coan, Etienne Wessler
    Tuon, Felipe Francisco
    JOURNAL OF CLINICAL VIROLOGY, 2024, 170
  • [2] Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment
    Corso, Giovanni
    Fusco, Nicola
    Guerini-Rocco, Elena
    Leonardi, Maria Cristina
    Criscitiello, Carmen
    Zagami, Paola
    Nicolo, Eleonora
    Mazzarol, Giovanni
    La Vecchia, Carlo
    Pesapane, Filippo
    Zanzottera, Cristina
    Tarantino, Paolo
    Petitto, Salvatore
    Bianchi, Beatrice
    Massari, Giulia
    Boato, Anthony
    Sibilio, Andrea
    Polizzi, Andrea
    Curigliano, Giuseppe
    De Scalzi, Alessandra Margherita
    Lauria, Federica
    Bonanni, Bernardo
    Marabelli, Monica
    Rotili, Anna
    Nicosia, Luca
    Albini, Adriana
    Calvello, Mariarosaria
    Mukhtar, Rita A.
    Robson, Mark E.
    Sacchini, Virgilio
    Rennert, Gad
    Galimberti, Viviana
    Veronesi, Paolo
    Magnoni, Francesca
    SEMINARS IN ONCOLOGY, 2024, 51 (3-4) : 106 - 122
  • [3] The Role of Amino Acids in the Diagnosis, Risk Assessment, and Treatment of Breast Cancer: A Review
    Bel'skaya, Lyudmila V.
    Gundyrev, Ivan A.
    Solomatin, Denis V.
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2023, 45 (09) : 7513 - 7537
  • [4] Diagnosis and treatment of influenza based on health insurance claims between the 2010-2011 and 2019-2020 influenza seasons in Japan
    Shimizu, Eiko
    Iwasaki, Kosuke
    Hongo, Yoshie
    Yoshida, Manami
    Kinoshita, Masahiro
    Hiroi, Shinzo
    Tamura, Daisuke
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (04) : 621 - 625
  • [5] COVID-19 related change in breast cancer diagnosis, stage, treatment, and case volume: 2019–2021
    Judith A. Malmgren
    Boya Guo
    Mary K. Atwood
    Paula Hallam
    Laura A. Roberts
    Henry G. Kaplan
    Breast Cancer Research and Treatment, 2023, 202 : 105 - 115
  • [6] Disparities in Breast Cancer Care-How Factors Related to Prevention, Diagnosis, and Treatment Drive Inequity
    Wilkerson, Avia D.
    Gentle, Corey K.
    Ortega, Camila
    Al-Hilli, Zahraa
    HEALTHCARE, 2024, 12 (04)
  • [7] COVID-19 related change in breast cancer diagnosis, stage, treatment, and case volume: 2019-2021
    Malmgren, Judith A.
    Guo, Boya
    Atwood, Mary K.
    Hallam, Paula
    Roberts, Laura A.
    Kaplan, Henry G.
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 202 (01) : 105 - 115
  • [8] Factors Contributing to Late Breast Cancer Diagnosis at the Brazzaville University Hospital in 2020, Congo: A Cross-Sectional Analytic Study
    Ilboudo, Michel
    Woromogo, Sylvain Honore
    Kabore, Dagnagnewende Dieudonne
    Zerbo, Nina Assanatou Jumelle
    Mbon, Jean Bernard Nkoua
    CANCER CONTROL, 2025, 32
  • [9] Nanobodies; new molecular instruments with special specifications for targeting, diagnosis and treatment of triple-negative breast cancer
    Bakherad, Hamid
    Ghasemi, Fahimeh
    Hosseindokht, Maryam
    Zare, Hamed
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [10] Nanobodies; new molecular instruments with special specifications for targeting, diagnosis and treatment of triple-negative breast cancer
    Hamid Bakherad
    Fahimeh Ghasemi
    Maryam Hosseindokht
    Hamed Zare
    Cancer Cell International, 22